课题基金 / 基金详情

Towards HIV and hepatitis C elimination: real-world trials and innovations in disease surveillance

Towards HIV and hepatitis C elimination: real-world trials and innovations in disease surveillance
消除艾滋病毒和丙型肝炎:疾病监测的现实试验和创新
批准号:
nhmrc : 1136970
负责人:
A/Pr Mark Stoove
金额:
$43.29万
依托单位国家:
澳大利亚
项目类别:
Research Fellowships
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2022-12-31

项目摘要

项目成果

A/Pr Mark Stoove的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Over the next five years I will undertake a program of research centred on developing and implementing strategies to help eliminate hepatitis C and HIV as major public health problems. In particular, I will use innovative monitoring systems and field trials to explore ways to diagnose and treat HIV and hepatitis C in vulnerable populations in a more timely way and study the influence this has on reducing the onward transmission of these infections to others.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying factors that improve the health of prisoners who inject drugs
  • 批准号:
    nhmrc : 1124368
  • 项目类别:
    Project Grants
  • 资助金额:
    $25.71万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Mark Stoove
  • 依托单位:
Determining patterns of cessation and relapse in a cohort of people who inject drugs
Reducing unintended pregnancies among female sex workers in Kenya using mHealth: a cluster randomised trial
Optimising treatment as prevention strategies for hepatitis C and HIV
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究